Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(2)
•••
Breakthorough
X
View Profile
View Bullboard History
Comment by
Breakthorough
on Sep 12, 2022 9:32am
RE:RE:RE:RE:RE:RE:Interesting (and hidden) data
The ESMO presentation (the PDF is already ay IMV website) was just a presentation of the Trial. The preliminary results have been announced for 3Q, though in the last corporate presentation they are
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Sep 12, 2022 9:28am
RE:RE:RE:RE:RE:Interesting (and hidden) data
No mention of ESMO presentation yet with only minutes prior to markets opening.If IVM has any interest in promoting the Company one would think they would be eager to release information early
...more
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Comment by
antigua1987
on Sep 12, 2022 9:03am
RE:IMV's tight hold on recent events
Update - quick look at esmo vitalize poster and there are no 'early results communicated in 3Q22'. Unless counting 9 onboarded patients since jan22 is a result according to imv.
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Sep 12, 2022 8:42am
IMV's tight hold on recent events
Is that for good or not-so-good reasons? ESMO poster/present was a quiet and late announcement. Maybe just easing Matasar into spotlight? You'd think where they'd just signed dlbcl's
...more
(2)
•••
bikkel78
X
View Profile
View Bullboard History
Comment by
bikkel78
on Sep 11, 2022 3:31pm
RE:RE:RE:RE:Interesting (and hidden) data
we just have to wait :)
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Sep 11, 2022 2:55pm
RE:RE:RE:Interesting (and hidden) data
According to the tweet, IMV have presented at the ESMO 11 am ECT. Hope they will post the presentation later today or tomorrow.I also checked the conference agenda for today and could not see any
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Sep 11, 2022 2:47pm
RE:RE:Interesting (and hidden) data
We’ll present at @myESMO 's #ESMO22 on our Phase 2b study, VITALIZE, investigating our lead DPX® product in #DLBCL. We're looking forward to discussing the ongoing study. Meet us there
...more
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Comment by
Biotech010
on Sep 11, 2022 1:36pm
RE:Interesting (and hidden) data
nice find! I cant find the poster online formulier todays esmo conference.... anyone did???
(2)
•••
Breakthorough
X
View Profile
View Bullboard History
Post by
Breakthorough
on Sep 10, 2022 3:43pm
Interesting (and hidden) data
If you go to page 19 of last Corporate presentation, you will find, on the left side, "Further evaluating data from SPIReL" (Phase 2a of DLBCL, being Phase 2b the VITALIZE TRIAL). There you
...more
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Comment by
Biotech010
on Sep 09, 2022 3:44pm
RE:Two Conference Presentations
stock is not on the radar.... the forum is dead.... i still expert yhe ceo to deliver
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Post by
Hideaway
on Sep 09, 2022 9:47am
Two Conference Presentations
IMV will be presenting at the at the ESMO in Paris on Sunday re the DLBCL Phase 2b Vitalize study and on Monday at the H C Wainwright Global Investor Conference. Will we hear any new information to
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 01, 2022 7:06am
New Press Release - IMV Inc. to Present at Two Investor Conferences in September
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that members of IMV’s executive management team will be presenting at two investor conferences...
read article.
(93)
•••
RockLobster1
X
View Profile
View Bullboard History
Comment by
RockLobster1
on Aug 24, 2022 9:48am
RE:RE:I hope you bought IMV. .65 cents will be 1000% profit.
I bought some more... seems a good place to buy and forget for a bit...
(0)
•••
TheBuzz21
X
View Profile
View Bullboard History
Comment by
TheBuzz21
on Aug 15, 2022 6:09am
RE:I hope you bought IMV. .65 cents will be 1000% profit.
Punchy message fo those of us that had virtually given up, Thanks, and very much hoping you're right.
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Comment by
Jthom376
on Aug 12, 2022 11:09pm
RE:I hope you bought IMV. .65 cents will be 1000% profit.
I thought you said it was about to delist from nasdaq???? Yup....
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario